产品: 磷酸化 IKK beta (Tyr188) 抗体
货号: AF3009
描述: Rabbit polyclonal antibody to Phospho-IKK beta (Tyr188)
应用: WB IHC IF/ICC
文献验证: WB
反应: Human, Mouse, Rat, Monkey
预测: Pig, Zebrafish, Bovine, Horse, Rabbit, Dog, Xenopus
蛋白号: O14920
RRID: AB_2834448

浏览相似产品>>

   规格 价格 库存
 50ul RMB¥ 1300 现货
 100ul RMB¥ 2400 现货
 200ul RMB¥ 3200 现货

货期: 当天发货

联系销售

产品描述

来源:
Rabbit
应用:
WB 1:500-1:2000, IHC 1:50-1:200, IF/ICC 1:100-1:500
*The optimal dilutions should be determined by the end user.
*Tips:

WB: 适用于变性蛋白样本的免疫印迹检测. IHC: 适用于组织样本的石蜡(IHC-p)或冰冻(IHC-f)切片样本的免疫组化/荧光检测. IF/ICC: 适用于细胞样本的荧光检测. ELISA(peptide): 适用于抗原肽的ELISA检测.

反应:
Human, Mouse, Rat, Monkey
克隆:
Polyclonal
特异性:
Phospho-IKK beta (Tyr188) Antibody detects endogenous levels of IKK beta only when phosphorylated at Tyrosine 188.
RRID:
AB_2834448
引用格式: Affinity Biosciences Cat# AF3009, RRID:AB_2834448.
偶联:
Unconjugated.
纯化:
The antibody is from purified rabbit serum by affinity purification via sequential chromatography on phospho-peptide and non-phospho-peptide affinity columns.
保存:
Rabbit IgG in phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. Store at -20 °C. Stable for 12 months from date of receipt.
别名:

展开/折叠

I kappa B kinase 2; I kappa B kinase beta; I-kappa-B kinase 2; I-kappa-B-kinase beta; IkBKB; IKK beta; IKK-B; IKK-beta; IKK2; IKKB; IKKB_HUMAN; IMD15; Inhibitor of kappa light polypeptide gene enhancer in B cells, kinase beta; Inhibitor of nuclear factor kappa-B kinase subunit beta; NFKBIKB; Nuclear factor NF-kappa-B inhibitor kinase beta;

抗原和靶标

免疫原:

A synthesized peptide derived from human IKK- beta around the phosphorylation site of Tyr188.

基因/基因ID:
描述:
IKK-beta is a kinase of the IKK family. Phosphorylates inhibitors of NF-kappa-B thus leading to the dissociation of the inhibitor/NF-kappa-B complex and ultimately the degradation of the inhibitor. Preferentially found as a heterodimer with IKK-alpha but also as an homodimer.

研究领域

· Cellular Processes > Cell growth and death > Apoptosis.   (View pathway)

· Environmental Information Processing > Signal transduction > MAPK signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > Ras signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > NF-kappa B signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > FoxO signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > mTOR signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > PI3K-Akt signaling pathway.   (View pathway)

· Environmental Information Processing > Signal transduction > TNF signaling pathway.   (View pathway)

· Human Diseases > Drug resistance: Antineoplastic > Antifolate resistance.

· Human Diseases > Endocrine and metabolic diseases > Type II diabetes mellitus.

· Human Diseases > Endocrine and metabolic diseases > Insulin resistance.

· Human Diseases > Endocrine and metabolic diseases > Non-alcoholic fatty liver disease (NAFLD).

· Human Diseases > Infectious diseases: Bacterial > Epithelial cell signaling in Helicobacter pylori infection.

· Human Diseases > Infectious diseases: Bacterial > Shigellosis.

· Human Diseases > Infectious diseases: Parasitic > Chagas disease (American trypanosomiasis).

· Human Diseases > Infectious diseases: Parasitic > Toxoplasmosis.

· Human Diseases > Infectious diseases: Viral > Hepatitis C.

· Human Diseases > Infectious diseases: Viral > Hepatitis B.

· Human Diseases > Infectious diseases: Viral > Influenza A.

· Human Diseases > Infectious diseases: Viral > Human papillomavirus infection.

· Human Diseases > Infectious diseases: Viral > HTLV-I infection.

· Human Diseases > Infectious diseases: Viral > Herpes simplex infection.

· Human Diseases > Infectious diseases: Viral > Epstein-Barr virus infection.

· Human Diseases > Cancers: Overview > Pathways in cancer.   (View pathway)

· Human Diseases > Cancers: Overview > MicroRNAs in cancer.

· Human Diseases > Cancers: Specific types > Pancreatic cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Prostate cancer.   (View pathway)

· Human Diseases > Cancers: Specific types > Chronic myeloid leukemia.   (View pathway)

· Human Diseases > Cancers: Specific types > Acute myeloid leukemia.   (View pathway)

· Human Diseases > Cancers: Specific types > Small cell lung cancer.   (View pathway)

· Organismal Systems > Immune system > Chemokine signaling pathway.   (View pathway)

· Organismal Systems > Development > Osteoclast differentiation.   (View pathway)

· Organismal Systems > Immune system > Toll-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > NOD-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > RIG-I-like receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > Cytosolic DNA-sensing pathway.   (View pathway)

· Organismal Systems > Immune system > IL-17 signaling pathway.   (View pathway)

· Organismal Systems > Immune system > Th1 and Th2 cell differentiation.   (View pathway)

· Organismal Systems > Immune system > Th17 cell differentiation.   (View pathway)

· Organismal Systems > Immune system > T cell receptor signaling pathway.   (View pathway)

· Organismal Systems > Immune system > B cell receptor signaling pathway.   (View pathway)

· Organismal Systems > Nervous system > Neurotrophin signaling pathway.   (View pathway)

· Organismal Systems > Endocrine system > Insulin signaling pathway.   (View pathway)

· Organismal Systems > Endocrine system > Adipocytokine signaling pathway.

文献引用

1). Overproduction of Gastrointestinal 5-HT Promotes Colitis-Associated Colorectal Cancer Progression via Enhancing NLRP3 Inflammasome Activation. Cancer Immunology Research, 2021 (PubMed: 34285037) [IF=8.1]

Application: WB    Species: Human and mouse    Sample: SW620, HT29, and CT26 cells

Figure 6.5-HT biosynthesis in colorectal cancer cells is upregulated by IL1β release in macrophages. A, Experiment design: Macrophages were activated by LPS (100 ng/mL, 4 hours) and ATP (5 mmol/L, 1 hour) with/without the IL1β production inhibitor Dia (10 μmol/L) for 5 hours, and then medium was replaced by fresh medium for another 6-hour incubation. Supernatants were then collected and used to incubate colorectal cancer (CRC) cells for 24 hours. mRNA expression of TPH1/Tph1 was detected by real-time PCR (B), and 5-HT concentration in supernatants was detected by ELISA (C) for SW620, HT29, and CT26 cells after incubation with conditional medium (CM) from activated macrophages (A-THP-1 CM, A-iBMDM CM) with/without Dia treatment. D, Protein expression of phospho-IKKβ (Tyr 188), IKKβ, phospho-NFκB p65 (Ser 536), NFκB p65, and TPH1 were detected by Western blotting in SW620, HT29, and CT26 cells after incubation with CM from activated macrophages (A-Φ CM; THP-1 for SW620/HT29 and iBMDM for CT26) with/without Dia treatment. mRNA expression of TPH1 (E) and 5-HT concentration in supernatants (G) from SW620 cells after incubation with CM from activated THP-1 cells with/without IL1RA (0.1 μg/mL), TLR1 (100 μmol/L), or BMS-345541 (4 μmol/L) for 24 hours. mRNA expression of TPH1 (F) and 5-HT concentration in supernatants (H) from HT29 cells after incubation with CM from activated THP-1 with/without IL1RA (0.1 μg/mL), TLR1 (100 μmol/L), and BMS-345541 (4 μmol/L) treatment for 24 hours. I, mRNA expression of Tph1 (left) and 5-HT concentration in supernatants (right) from CT26 cells after incubation with CM from activated iBMDM cells for 24 hours, and with/without TLR1 (100 μmol/L) or BMS-345541 (4 μmol/L) treatment. B, C, and E–I, Data represent mean ± SD for at least three independent experiments; one-way ANOVA. J, Representative IHC photos for TPH1 in tumor tissues from the CT26 and iBMDM coimplanted subcutaneous allograft colorectal cancer mouse model (see Fig. 7). Scale bar: 50 μm. WT, wild-type. **, P < 0.01. n.s., no significant differences.

2). Antidepressant-like effects of helicid on a chronic unpredictable mild stress-induced depression rat model: Inhibiting the IKK/IκBα/NF-κB pathway through NCALD to reduce inflammation. International Immunopharmacology, 2021 (PubMed: 33578182) [IF=4.8]

Application: WB    Species: rat    Sample: hippocampus

Fig. 10. The effects of the IKK/IκBα/NF-κB signaling pathway in the hippocampus after AAV-siNCALD. (A) Representative NCALD, IKKβ, p-IKKβ, IкBα, p- IкBα, NF-кB, β-actin, and Lamin B western blot bands. (B), (C), (D), (E), (F), (G), (H) The relative ratios of the grayscale values of NCALD, IKKβ, p-IKKβ, IкBα, pIкBα, and NF-кB to the corresponding β-actin or Lamin B, n = 4. ###P < 0.001, CUMS + saline vs. sham; *P < 0.05; **P < 0.01; ***P < 0.001, CUMS + saline vs. CUMS + AAV-siNCALD. All data are shown as the mean ± SEM.

3). Effects of tumor necrosis factor-α on glucose uptake in human granulosa cells under high androgen conditions. Iranian Journal of Basic Medical Sciences, 2023 [IF=2.1]

限制条款

产品的规格、报价、验证数据请以官网为准,官网链接:www.affbiotech.com | www.affbiotech.cn(简体中文)| www.affbiotech.jp(日本語)

产品的数据信息为Affinity所有,未经授权不得收集Affinity官网数据或资料用于商业用途,对抄袭产品数据的行为我们将保留诉诸法律的权利。

产品相关数据会因产品批次、产品检测情况随时调整,如您已订购该产品,请以订购时随货说明书为准,否则请以官网内容为准,官网内容有改动时恕不另行通知。

Affinity保证所销售产品均经过严格质量检测。如您购买的商品在规定时间内出现问题需要售后时,请您在Affinity官方渠道提交售后申请。

产品仅供科学研究使用。不用于诊断和治疗。 

产品未经授权不得转售。

Affinity Biosciences将不会对在使用我们的产品时可能发生的专利侵权或其他侵权行为负责。Affinity Biosciences, Affinity Biosciences标志和所有其他商标所有权归Affinity Biosciences LTD.